| Financial Year |
March 31 2023 |
| Monetary Funds |
1,038,330,425.04 |
| Held-for-trading Financial Assets |
2,054,081,607.97 |
| Notes Receivable |
-- |
| Accounts Receivable |
64,829,745.91 |
| Advances to Suppliers |
9,469,633.07 |
| Other Receivables |
23,649,278.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
962,951,128.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,909,107.68 |
| Total Current Assets |
4,185,220,925.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
51,224,227.90 |
| Investment Properties |
1,365,610.52 |
| Fixed Assetes |
1,548,699,748.17 |
| Under-construction Projects |
71,248,954.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
94,556,337.54 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
128,260,570.37 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
523,824.84 |
| Deferred Income Tax Assets |
39,108,314.06 |
| Other Non-Current Assets |
6,930,249.00 |
| Sub-Total of Non-Current Assets |
1,998,304,821.26 |
| Total Assets |
6,183,525,746.96 |
| Short-Term Loans |
365,381,256.95 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,000,000.00 |
| Accounts Payable |
371,345,205.80 |
| Accounts Received In Advance |
264,645.42 |
| Employee Compensation Payable |
96,041,141.60 |
| Taxes Payable |
3,152,313.41 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
426,293,457.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,219,945.86 |
| Other Current Liabilities |
1,118,149.06 |
| Sub-Total of Current Liabilities |
1,299,257,140.22 |
| Long-term Loans |
140,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,387,496.70 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
194,760,063.99 |
| Total Liabilities |
1,494,017,204.21 |
| Paid-In Capital(Or Share Stock) |
860,538,727.00 |
| Capital Surplus |
1,539,077,735.11 |
| Surplus Reserve |
229,397,299.64 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,907,532,915.01 |
| Minority Stockholder's Interest |
152,058,517.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,537,450,024.94 |
| Owner's Equity（Stockholder's Equity） |
4,689,508,542.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,183,525,746.96 |
